- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05840146
Kineesiotaping for Patients With LCPD
April 21, 2023 updated by: Sezen Karaborklu Argut, Istanbul University - Cerrahpasa (IUC)
Effects of Kinesiotaping in Patients With Legg-Calvé-Perthes Disease: A Randomized, Double-blind, Placebo-controlled Trial
Kinesiotaping is increasingly being used as a complement to musculoskeletal pain management.
This study aimed to evaluate the immediate clinical efficacy of kinesiotaping on pain and pain-related symptoms of Legg-Calvé-Perthes Disease (LCPD).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Kinesio taping is increasingly being used as a complement to musculoskeletal pain management.
A randomized, double-blind, placebo-controlled clinical trial was conducted.
Activity-related hip pain, passive and pain limited hip range of motion, gluteus medius muscle strength, function and balance were assessed.
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Istanbul, Turkey
- Istanbul University-Cerrahpasa
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Having received unilateral LCPD diagnosis,
- Anterior hip pain minimum three points on 10-cm Visual Analog Scale (VAS) over the previous week,
- Having the following symptoms; weakness of gluteus medius muscle and patient-reported complaints on function or balance
Exclusion Criteria:
- Having a history of any other hip pathologies,
- Having allergy to polyacrylate adhesive,
- Having used analgesic medication within the previous three days.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Kinesiotaping group
Kinesiotape was applied to the lateral side of the affected hip for gluteus medius muscle.
Each patient was positioned lying down with the affected side up, and two I-strips were used.
|
Two I-strips were used:
|
Sham Comparator: Sham taping group
Sham tape was applied with a single I-strip without tension in tape or muscle stretch.
After paper backing was completely removed, tape was essentially placed on the skin across the lateral side of the affected hip.
|
A single I-strip without tension in tape or muscle stretch.
After paper backing was completely removed, tape was essentially placed on the skin across the lateral side of the hip.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Immediate Clinical Efficacy on Activity Related Hip
Time Frame: The change between T1 (baseline) to T2 (thirty minutes later from the application)
|
Horizontal 10 cm VAS (0, no pain; 10, the worst pain ever possible)
|
The change between T1 (baseline) to T2 (thirty minutes later from the application)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Immediate Clinical Efficacy on Hip Abduction ROM
Time Frame: The change between T1 (baseline) to T2 (thirty minutes later from the application)
|
goniometric range of motion (ROM)
|
The change between T1 (baseline) to T2 (thirty minutes later from the application)
|
Immediate Clinical Efficacy on Functional Task Durations
Time Frame: The change between T1 (baseline) to T2 (thirty minutes later from the application)
|
10-meters walk task duration (sec) and 10-step climbing task duration (sec)
|
The change between T1 (baseline) to T2 (thirty minutes later from the application)
|
Immediate Clinical Efficacy on Balance test durations
Time Frame: The change between T1 (baseline) to T2 (thirty minutes later from the application)
|
One leg stance test duration (sec) and Tandem walk test duration (sec)
|
The change between T1 (baseline) to T2 (thirty minutes later from the application)
|
Immediate Clinical Efficacy on Gluteus medius muscle strength
Time Frame: The change between T1 (baseline) to T2 (thirty minutes later from the application)
|
muscle strength by handheld dynamometer (Ibs)
|
The change between T1 (baseline) to T2 (thirty minutes later from the application)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 25, 2017
Primary Completion (Actual)
April 6, 2020
Study Completion (Actual)
January 11, 2021
Study Registration Dates
First Submitted
March 20, 2023
First Submitted That Met QC Criteria
April 21, 2023
First Posted (Actual)
May 3, 2023
Study Record Updates
Last Update Posted (Actual)
May 3, 2023
Last Update Submitted That Met QC Criteria
April 21, 2023
Last Verified
April 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20151704-1746
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Legg-Calve-Perthes Disease
-
Texas Scottish Rite Hospital for ChildrenJohns Hopkins University; Baylor College of Medicine; Children's Hospital of... and other collaboratorsEnrolling by invitationLegg Calve Perthes DiseaseUnited States, Canada, Puerto Rico, Sweden, Ireland, Norway, Spain, Poland, Australia, Brazil, China, Germany, India, United Kingdom, Switzerland
-
Seattle Children's HospitalTerminated
-
Oslo University HospitalSophies Minde FoundationEnrolling by invitation
-
British Columbia Children's HospitalUnknownLegg-Calvé-Perthes DiseaseCanada
-
Assaf-Harofeh Medical CenterCompletedLegg-Calvé-Perthes DiseaseIsrael
-
University of British ColumbiaCompleted
-
Zimmer BiometCompletedOsteoarthritis | Rheumatoid Arthritis | Avascular Necrosis | Traumatic Arthritis | Legg-Perthes DiseaseKorea, Republic of
-
Assiut UniversityUnknown
-
Zimmer BiometActive, not recruitingOsteoarthritis | Rheumatoid Arthritis | Avascular Necrosis | Traumatic Arthritis | Legg-perthes DiseaseKorea, Republic of
-
Istituto Ortopedico RizzoliCompleted
Clinical Trials on Kinesiotaping
-
Cairo UniversityRecruiting
-
Istinye UniversityRecruiting
-
Hacettepe UniversityCompletedSports Performance in ChildrenTurkey
-
Riphah International UniversityCompletedKnee OsteoarthritisPakistan
-
University of LiegeCompleted
-
Etimesgut Military HospitalBagcilar Training and Research HospitalCompletedSprain of AnkleTurkey
-
Sultan Abdulhamid Han Training and Research Hospital...Completed
-
Riphah International UniversityCompletedSacral DisorderPakistan
-
Ondokuz Mayıs UniversityCompletedInfant, Newborn, Diseases | Respiratory Distress Syndrome | Premature | Preterm | Neonatal Respiratory DistressTurkey